Daniel Aharoni is assistant professor of neurology at the University of California, Los Angeles (UCLA). He received his Ph.D. in physics from UCLA, where he worked in high- and low-energy particle physics before shifting his focus to neurophysics. Aharoni stayed at UCLA for a postdoctoral fellowship under Baljit Khakh, Alcino Silva and Peyman Golshani, spearheading the technical development of the open-source UCLA Miniscope Project. Aharoni’s lab integrates engineering, neuroscience and physics to create innovative tools that address complex challenges in neuroscience. His research aims to enhance our understanding of neural circuits, advance tool design for neuroscience, and ensure equitable access to pioneering technologies.
Daniel Aharoni
Assistant professor of neurology
University of California, Los Angeles
From this contributor
Designing an open-source microscope
Funding for the development of open-source tools is on the rise, but support for their maintenance and dissemination, both crucial for their meaningful uptake, remains a major challenge.
Designing an open-source microscope
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.